Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality.
Evans, D Gareth R Harkness, E Howell, Anthony Wilson, M Hurley, E Holmen, M Tharmaratnam, K Hagen, A Lim, Y Maxwell, A J
Evans, D Gareth R
Harkness, E
Howell, Anthony
Wilson, M
Hurley, E
Holmen, M
Tharmaratnam, K
Hagen, A
Lim, Y
Maxwell, A J
Citations
Altmetric:
Abstract
The addition of annual MRI screening to mammography has heightened optimism that intensive screening along with improved treatments may substantially improve life expectancy of women at high risk of breast cancer. However, survival data from BRCA2 mutation carriers undergoing intensive combined breast screening are scarce.
Description
Date
2016
Publisher
Collections
Keywords
Type
Article
Citation
Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality. 2016, 14:8 Hered Cancer Clin Pract